UBS Group
INVA icon

UBS Group’s Innoviva INVA Stock Holding History

UBS Group’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-500,000
Closed -$6.99M – 8198
2020
Q2 		$6.99M Sell
500,000
-90,000
-15% -$1.22M ﹤0.01% 1791
2020
Q1 		$6.94M Buy
+590,000
New +$7.8M ﹤0.01% 1663

Other funds holding INVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group's INVA Position: Q1 2026 in Review

UBS Group reduced its Innoviva (INVA) stake by 14% in Q1 2026, selling an estimated $1.53M and leaving 437,093 shares worth $10.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3328.

UBS Group first reported a position in INVA in Q4 2014 and has held it in 46 quarters since. The position peaked at $17M in Q2 2018. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • UBS Group held 437,093 shares of Innoviva worth $10.2M as of Q1 2026.
  • UBS Group sold 71,085 Innoviva shares in Q1 2026, an estimated $1.53M.
  • Innoviva made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3328 holding.
  • UBS Group first reported a position in Innoviva in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Innoviva position peaked at $17M in Q2 2018.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.